4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MicroPort CardioFlow Medtech Corporation (2160) operates in the Medical Devices industry and is headquartered in Shanghai, China with about 1,415 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, 2160 reported $57M in revenue and ($19M) in net income.
MicroPort CardioFlow Medtech Corporation, together with its subsidiaries, researches, develops, manufactures, and sells medical devices for the treatment of structural heart disease and cardiac rhythm management in China, Europe, the Middle East, Africa, Asia, North America, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $57M | $51M | $47M | $36M | — |
| Gross Profit | $37M | $35M | $32M | $24M | — |
| Operating Income (EBIT) | ($20M) | ($22M) | ($50M) | ($48M) | — |
| Net Income | ($19M) | ($7M) | ($66M) | ($66M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $670M | $372M | $364M | $435M | — |
| Total Liabilities | $413M | $63M | $34M | $36M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2160 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms